USANA Health Sciences, Inc. · NYSE:USNA

USANA Health Sciences — Q3 2026 Earnings Presentation

18 slides from USANA Health Sciences's earnings presentation, Nov 4, 2026

  1. Slide 1: Q3 2026 Management Commentary: Key Financial Results

    USANA Health Sciences, Inc. November 3, 2026 Q3 2026 Management Commentary Key Financial Results Quarter ended September October 3, 27, Year-Over- 2026 2025 Year Sequentially Net Sales $206 $214 -4% -8% Net Loss $(5.6) $(6.5) N/A N/A Diluted EPS $(0.30) $(0.36) N/A N/A Adjusted Diluted EPS(1) $(0.11

  2. Slide 2: Overview and Core Nutritional commentary

    This financial position gives us the flexibility to keep investing in our strategic initiatives while maintaining financial discipline. We are also updating our fiscal 2026 outlook to reflect lower expectations for Rise Wellness and our decision to invest at Hiya to accelerate subscriber growth, par

  3. Slide 3: Core Nutritional initiatives and Hiya results

    consumers, with new products we plan to begin introducing in 2027. In August, we hosted our Live 2026 Americas Convention in San Diego, and following the event we launched Clear Protein + Creatine Mix, building on the launch of Glow earlier this year. We also continue to modernize the technology tha

  4. Slide 4: Hiya channels and Rise Wellness

    brand awareness in its first year of operation. Together, these channels are broadening Hiya’s consumer reach and creating more diversified avenues for growth as the brand heads into the fourth quarter and 2027. Rise Wellness continues to scale, with year-to-date net sales of approximately $21 milli

  5. Slide 5: Consolidated Balance Sheet

    Consolidated Balance Sheet We ended the third quarter with $179 million in cash and cash equivalents and zero debt. We did not repurchase any shares during the quarter and had approximately $34 million remaining under the current share repurchase authorization as of October 3, 2026. Inventories decr

  6. Slide 6: Income statement discussion: incentives and SG&A

    Wellness, which do not pay out Brand Partner Incentives. For the Core Nutritional business, Brand Partner Incentives decreased 200 basis points year-over-year to 42.1% of segment net sales, largely driven by compensation plan expenses in last year's quarter that did not recur in the current-year qua

  7. Slide 7: Q3 2026 Segment Results: Core Nutritional

    Q3 2026 Segment Results Core Nutritional Core Nutritional Year-Over- Year-Over-Year Q3 2026 Year (Constant Currency) Sequentially Net Sales $171 million -3% -6% -11% Active Customers 356,000 -8% N/A -7% Asia Pacific Region Year-Over- Year-Over-Year Q3 2026 Year (Constant Currency) Sequentially Net S

  8. Slide 8: Hiya, Rise Wellness and Fiscal Year 2026 Outlook

    Hiya Health Q3 2026 Year-Over-Year Sequentially Net Sales $32 million +2% +12% Active Monthly Subscribers 195,500 +1% +18% Rise Wellness Q3 2026 Year-Over-Year Sequentially Net Sales $4 million -45% +7% Fiscal Year 2026 Outlook The Company is updating its outlook for fiscal year 2026, as follows: Fi

  9. Slide 9: Outlook assumptions and strategic focus

    Nutritional. We expect continued sequential progress from Hiya during the fourth quarter on both net sales and Adjusted EBITDA. Our fiscal 2026 outlook assumes certain Rise Wellness retail orders ship in the fourth quarter. If some of these orders shift to the first quarter of 2027, 2026 results cou

  10. Slide 10: Correction of Previously Reported Adjusted EBITDA Attributable to USANA

    Correction of Previously Reported Adjusted EBITDA Attributable to USANA In preparing its third quarter results, the Company identified an omission in its second quarter 2026 reconciliation of net (loss) earnings to Adjusted EBITDA attributable to USANA. The $29.1 million Hiya goodwill impairment was

  11. Slide 11: Non-GAAP Financial Measures

    (3) Free cash flow is a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Net Cash Provided by (Used in) Operating Activities (GAAP) to Free Cash Flow (Non-GAAP)” in this Management Commentary for an explanation and reconciliation of this non-GAAP finan

  12. Slide 12: Free cash flow and non-GAAP definitions

    Free cash flow (non-GAAP) is net cash provided by (used in) operating activities (its most directly comparable GAAP financial measure) less purchases of property and equipment. Management believes free cash flow is a useful measure of the cash the business generates, after investing in property and

  13. Slide 13: Reconciliation of Net Loss to Adjusted EBITDA

    Reconciliation of Net Loss (GAAP) to Adjusted EBITDA (non-GAAP) (in thousands) Quarter ended October 3, September 27, 2026 2025 Net loss attributable to USANA (GAAP) $ (5,556) $ (6,522) Net loss attributable to noncontrolling interest (1,334) (140) Net loss $ (6,890) $ (6,662) Adjustments: Income ta

  14. Slide 14: Reconciliation of Diluted Loss Per Share and Free Cash Flow

    Reconciliation of Diluted Loss Per Share (GAAP) to Adjusted Diluted Loss Per Share (non-GAAP) (in thousands, except per share data) Quarter ended October 3, September 27, 2026 2025 Net loss attributable to USANA (GAAP) $ (5,556) $ (6,522) Loss per common share - Diluted $ (0.30) $ (0.36) Weighted Av

  15. Slide 15: Operating Results as a Percentage of Net Sales

    Operating Results as a Percentage of Net Sales (unaudited) Quarter ended October 3, 2026 September 27, 2025 Core Core Nutritional Hiya Rise Consolidated Nutritional Hiya Rise Consolidated Net sales 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% Cost of sales 19.9% 33.9% 110.4% 23.7% 18.8% 3

  16. Slide 16: Conference Call and Safe Harbor

    Conference Call USANA’s management team will hold a conference call and webcast to discuss today’s announcement with investors on Wednesday, November 4, 2026, at 11:00 AM Eastern Time. Investors may listen to the call by accessing USANA’s website at http://ir.usana.com. The call will consist of brie

  17. Slide 17: Forward-looking statement risk factors

    associated with our launch of new products or reformulated existing products; risks related to Hiya’s ability to adapt to changes in the digital marketing environment to continue to generate customer acquisition, including changes in social media advertising algorithms; risks related to Hiya’s abili

  18. Slide 18: Forward-looking statement risk factors (continued)

    operations; the ability to retain key personnel of USANA, Hiya and Rise Wellness; the ability to realize the benefits of the Hiya acquisition, including efficiencies and cost synergies; the ability to successfully integrate Hiya’s business with USANA’s business, at all or in a timely manner; and the

USANA Health Sciences — Q3 2026 Earnings Presentation on 6ix